home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Understanding and Preparing for FDA's New Part 11 Inspection Program - Webinar By GlobalCompliancePanel

 
  November 29, 2010  
     
 
GlobalCompliancePanel, Online Training Webinar
2011-01-25


Overview: Within the next few weeks and months the FDA will conduct a series of Part 11 related inspections.

Planned routine inspections will be extended to evaluate the companies' practices to ensure accuracy, integrity, authenticity and availability of electronic records, and the FDA plans additional 'for cause inspections'. Inspections are planned for US but also in foreign countries. The program is the long awaited next step for Part 11 and nevertheless it came as a surprise to the industry.

Reference material for easy implementation:
  • 25 recent FDA Warning Letters with part 11 violations.
  • 15 Case Studies: Implementing Part 11
  • Validation templates and examples
Areas Covered In the Seminar:
  • FDA inspections: Preparation, conducts, follow up
  • Learning from past Part 11 inspections
  • Scope of the new Part 11 program: time frame, expected outcome
  • Criteria for selection of target companies
  • What inspectors are looking for
  • How to prepare your company for the upcoming inspections
  • Learning from previous inspections with focus on Part 11 and computer validation: most frequently cited deviations
  • How to fill gaps short term
  • Developing a program for long term
  • Creating the right documentation to satisfy the inspectors
  • Most likely next steps after the inspection program
Who will benefit:
  • IT managers and system administrators
  • QA managers and personnel
  • QC and Lab managers
  • Validation specialists
  • Regulatory affairs
  • Training departments
  • Documentation department
  • Consultants
 
 
Organized by: GlobalCompliancePanel
Invited Speakers:
Ludwig Huber, Ph.D., is Director of Labcompliance and Chief Advisor for global FDA compliance at Agilent Technologies. He is the editor of Labcompliance, the global on-line resource for validation and compliance issues for laboratories. He is the author of the books "Validation and Qualification in Analytical Laboratories, and "Validation of Computerized Analytical and Networked Systems", Informa Healthcare.
 
Deadline for Abstracts: 2011-01-25
 
Registration:
Tuesday, January 25, 2011  
10:00 AM PST | 01:00 PM EST
Live live online training only for one participant
Price: $245.00
 
 
 
Corporate Live 4 to 10 participants from a single location (For multiple locations contact Customer Care)
Price: $995.00
 

Recorded Access recorded version only for one participant; unlimited viewing for 6 months ( Access information will be emailed 24 hours after the completion of live webinar)
Price: $295.00
 
E-mail: webinars@globalcompliancepanel.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.